ClinicalTrials.gov
public full text
Public Domain
One vs Two Weeks Treatment for H.Pylori Eradication A RANDOMIZED NON-INFERIORITY PLACEBO CONTROLLED TRIAL
1. To assess the efficacy of the duration of Vonoprazan based triple regimen (one versus two weeks), in the eradication of H-pylori among patients attending gastroenterology clinics of Karachi, Pakistan. 2. To assess the improvement in the quality of life of patients receiving Vonoprazan as part of the triple regimen.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- 10 vs 14 Days Triple Therapy : H.Pylori Infection Eradication#874327
- 7 Days vs. 14 Days of Vonoprazan-based Triple Therapy for H. Pylori Eradication#1089095
- Safety, Efficacy of Pylera BID Dosing in Eradication of H. Pylori#1030001
- Vonoprazan for Helicobacter Pylori Eradication in Adolescents#811188
- Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori Infection#1351926
Record · ID 1439453
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive